American Academy of Pediatrics. Commitee on Quality Improvement and Subcommittee on attention-Deficit/Hyperactivity Disorder : Clinical practice guideline : diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics, 105: 1158-1170,2000.
Berridge, C. W., Devilbiss, D. M., Andrzejewski, M. E. et al. : Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol. Psychiatry, 60 : 1111-1120,2006.
Bymaster, F. P., Katner, J. S., Nelson, D. L. et al. : Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat : a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology, 27 : 699-711,2002.
Bymaster, F. P., Dreshfield-Ahmad, L. J., Threlkeld, P. G. et al. : Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology, 25 : 871-880, 2001.